mizoribine has been researched along with Kidney Diseases in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakai, N; Wada, T | 1 |
| Endo, A; Fujinaga, S; Hara, S; Murakami, H; Murano, Y; Nakagawa, M; Ohtomo, Y; Sakuraya, K; Shimizu, T; Someya, T | 1 |
| Doi, S; Doi, T; Kohno, N; Masaki, T; Nakashima, A; Ueno, T; Yokoyama, Y | 1 |
| Imaizumi, T; Tanaka, H; Tsuruga, K | 1 |
| Fujieda, M; Gotoh, Y; Hashimoto, Y; Kaneda, H; Morooka, M; Nagai, T; Ohta, K; Satomura, K; Shimizu, M; Takaai, M; Uemura, O; Ushijima, K; Wada, N; Yamada, M; Yamada, T | 1 |
| Jeong, HJ; Kim, JH; Kim, PK; Lee, YH; Lim, BJ; Shin, JI | 1 |
| Aihara, Y; Fujinaga, S; Harada, T; Imagawa, T; Ito, S; Nagahama, K; Nakamura, T; Sasaki, T; Yokota, S | 1 |
| Ito, S | 1 |
| Fujinaga, S; Hara, S; Murakami, H; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Kawasaki, Y | 1 |
| Fujieda, M; Goto, Y; Hashimoto, Y; Ishida, K; Kaneda, H; Morooka, M; Ohta, K; Satomura, K; Shimizu, M; Takaai, M; Uemura, O; Ushijima, K; Wada, N; Yamada, M; Yamada, T | 1 |
| Harada, T; Horita, Y; Kohno, S; Miyazaki, M; Nishioka, Y; Suyama, N; Tadokoro, M; Taura, K | 1 |
| Harada, T; Kanekake, H; Nishikido, M | 1 |
| Fujita, T; Hirabayashi, S; Katoh, N; Kinukawa, T; Matsuura, O; Ohshima, S; Ono, Y; Sahashi, M; Takeuchi, N; Yamada, S | 1 |
| Kawamura, T; Sakai, T; Shirasawa, T | 1 |
| Yokota, S | 1 |
| Broaddus, TW; Cain, GR; Cowgill, LD; Gourley, IM; Gregory, CR; Ishizaki, G; Patz, JD; Willits, NH | 1 |
| Agishi, T; Fuchinoue, S; Honda, H; Ota, K; Takahashi, K; Teraoka, S; Toma, H; Yagisawa, T | 1 |
| Aso, K; Endo, T; Koshiba, K; Kumano, K; Nakayama, Y; Ohkubo, M; Osakabe, T; Sato, K; Uchida, H; Yokota, K | 1 |
4 review(s) available for mizoribine and Kidney Diseases
| Article | Year |
|---|---|
Mizoribine in the treatment of pediatric-onset glomerular disease.
Topics: Animals; Cell Movement; Chemokine CCL2; Child; Disease Progression; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Kidney Glomerulus; Macrophages; Mesangial Cells; Podocytes; Rats; Ribonucleosides | 2015 |
[Renal involvement in connective tissue diseases].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Connective Tissue Diseases; Humans; Immunosuppressive Agents; Kidney Diseases; Methylprednisolone; Pulse Therapy, Drug; Ribonucleosides; Tacrolimus | 2009 |
Mizoribine: a new approach in the treatment of renal disease.
Topics: Adolescent; Adult; Child; Female; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Lupus Nephritis; Middle Aged; Nephrotic Syndrome; Ribonucleosides; Treatment Outcome | 2009 |
[Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclophosphamide; Cyclosporine; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Recombinant Fusion Proteins; Ribonucleosides; Sphingosine | 2006 |
2 trial(s) available for mizoribine and Kidney Diseases
| Article | Year |
|---|---|
Immunosuppression with low-dose cyclosporine, mizoribine, and steroids in living-related kidney transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Cyclosporine; Drug Therapy, Combination; Family; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Prednisolone; Ribonucleosides; Steroids; Tissue Donors | 1994 |
Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone.
Topics: Adult; Clinical Trials as Topic; Cyclosporins; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Kidney; Kidney Diseases; Kidney Transplantation; Liver Diseases; Male; Middle Aged; Prednisolone; Ribonucleosides | 1987 |
14 other study(ies) available for mizoribine and Kidney Diseases
| Article | Year |
|---|---|
[Immunosuppressants-induced kidney injury].
Topics: Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Ribonucleosides; TOR Serine-Threonine Kinases | 2016 |
Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats.
Topics: Angiotensin Receptor Antagonists; Animals; Body Weight; Cyclosporine; Drug Synergism; Immunosuppressive Agents; Kidney Diseases; Male; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; Ribonucleosides | 2014 |
Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats.
Topics: Aldosterone; Animals; Blood Pressure; Caspase 1; DNA Nucleotidylexotransferase; Epithelial Sodium Channels; Fibrosis; Hypertension; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Ribonucleosides; Salts; Sodium Chloride | 2014 |
Population pharmacokinetics of mizoribine in pediatric patients with kidney disease.
Topics: Administration, Oral; Adolescent; Age Factors; Area Under Curve; Bayes Theorem; Biological Availability; Child; Child, Preschool; Drug Dosage Calculations; Female; Humans; Immunosuppressive Agents; Infant; Intestinal Absorption; Japan; Kidney Diseases; Linear Models; Male; Models, Biological; Ribonucleosides | 2016 |
Influence of cyclosporine A on glomerular growth and the effect of mizoribine and losartan on cyclosporine nephrotoxicity in young rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Histocytochemistry; Kidney; Kidney Diseases; Kidney Glomerulus; Losartan; Male; Rats, Sprague-Dawley; Ribonucleosides | 2016 |
Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence.
Topics: Adolescent; Biopsy; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Ribonucleosides; Sarcoidosis; Secondary Prevention; Steroids | 2009 |
Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cyclosporine; Disease Progression; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides | 2009 |
Evaluation of limited sampling designs to estimate maximal concentration and area under the curve of mizoribine in pediatric patients with renal disease.
Topics: Adolescent; Area Under Curve; Bayes Theorem; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Ribonucleosides | 2011 |
Mizoribine induces remission of relapsed ANCA-associated renal vasculitis.
Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Diseases; Recurrence; Remission Induction; Ribonucleosides; Vasculitis | 2006 |
Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin.
Topics: Actins; Animals; Cell Movement; Female; Fibrosis; Immunosuppressive Agents; Kidney Diseases; Kidney Tubules; Macrophages; Muscle, Smooth; Rats; Rats, Sprague-Dawley; Ribonucleosides; Ureteral Obstruction | 1997 |
Foreword--Mizoribine: a new immunosuppressive drug for kidney diseases and rheumatic diseases.
Topics: Humans; Immunosuppressive Agents; Kidney Diseases; Rheumatic Diseases; Ribonucleosides | 2002 |
[A new pharmacotherapy of renal diseases].
Topics: Adolescent; Animals; Cyclosporins; Drug Evaluation, Preclinical; Esculin; Free Radicals; Humans; Immunosuppressive Agents; Kidney Diseases; Leukotrienes; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred Strains; Oxygen; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Ribonucleosides | 1989 |
Effects of combination cyclosporine/mizoribine immunosuppression on canine renal allograft recipients.
Topics: Animals; Bacteriuria; Blood Cell Count; Body Weight; Cyclosporins; Dogs; Drug Therapy, Combination; Female; Graft Survival; Immunosuppression Therapy; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Ribonucleosides; Urine | 1988 |
Cyclosporine immunosuppression for more than three years in kidney transplants.
Topics: Azathioprine; Creatinine; Cyclosporins; Graft Rejection; Humans; Immunosuppression Therapy; Kidney; Kidney Diseases; Kidney Transplantation; Ribonucleosides; Time Factors | 1988 |